Michael Barbella, Managing Editor09.22.22
Brain Scientific's NeuroCap is now approved for sale in Europe.
“The CE mark approval is yet another certification proving the effectiveness of Brain Scientific’s technologies,” said Daniel Cloutier, CEO of LOK Corporation. “We have seen strong demand from European neurologists and distributors for the NeuroCap™, and now with the CE mark Brain Scientific can start selling to medical facilities in Europe.”
Brain Scientific has developed two distinct devices to streamline EEG prep, testing, and diagnosis. NeuroCap has 22 pre-gelled electrodes making it a suitable option for most clinical EEG tests, including routine EEGs that are often used for stroke and epilepsy patients. The fixed electrode placement is in accordance with the international 10-20 system. NeuroEEG is a 21-channel amplifier that provides clinicians with the same quality as traditional EEG equipment.
“Our neurology products are accelerating access to EEG testing both in hospitals and in the field,” said Hassan Kotob, chairman and CEO of Brain Scientific. “The CE mark is a vital step forward as we increase our market penetration in Europe.”
The NeuroCap is a U.S. Food and Drug Administration (FDA) 510(k)-cleared, pre-gelled disposable EEG headset for clinical use. The NeuroCap allows any clinician to prepare a patient for an EEG exam in a fraction of the time normally spent applying individual electrodes. The NeuroCap can be used in nearly any environment, including rural hospitals, ambulances, private practices, and athletic events, vastly expanding access to EEG testing. It is currently available in four sizes, including pediatric sizes.
Brain Scientific is a medical technology company with multiple patents and FDA-cleared products. Brain Scientific has two product lines covering neurology and precision motion.
“The CE mark approval is yet another certification proving the effectiveness of Brain Scientific’s technologies,” said Daniel Cloutier, CEO of LOK Corporation. “We have seen strong demand from European neurologists and distributors for the NeuroCap™, and now with the CE mark Brain Scientific can start selling to medical facilities in Europe.”
Brain Scientific has developed two distinct devices to streamline EEG prep, testing, and diagnosis. NeuroCap has 22 pre-gelled electrodes making it a suitable option for most clinical EEG tests, including routine EEGs that are often used for stroke and epilepsy patients. The fixed electrode placement is in accordance with the international 10-20 system. NeuroEEG is a 21-channel amplifier that provides clinicians with the same quality as traditional EEG equipment.
“Our neurology products are accelerating access to EEG testing both in hospitals and in the field,” said Hassan Kotob, chairman and CEO of Brain Scientific. “The CE mark is a vital step forward as we increase our market penetration in Europe.”
The NeuroCap is a U.S. Food and Drug Administration (FDA) 510(k)-cleared, pre-gelled disposable EEG headset for clinical use. The NeuroCap allows any clinician to prepare a patient for an EEG exam in a fraction of the time normally spent applying individual electrodes. The NeuroCap can be used in nearly any environment, including rural hospitals, ambulances, private practices, and athletic events, vastly expanding access to EEG testing. It is currently available in four sizes, including pediatric sizes.
Brain Scientific is a medical technology company with multiple patents and FDA-cleared products. Brain Scientific has two product lines covering neurology and precision motion.